# Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

> **NCT00693069** · PHASE3 · COMPLETED · sponsor: **Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal** · enrollment: 120 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00693069
- **Lead sponsor:** Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693069, "Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00693069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*